이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

SciBase Holding 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Pia Renaudin

최고 경영자

SEK 648.0k

총 보상

CEO 급여 비율	77.8%
CEO 임기	less than a year
CEO 소유권	n/a
경영진 평균 재임 기간	9.5yrs
이사회 평균 재임 기간	7.3yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Pia Renaudin 의 보수는 SciBase Holding 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	-SEK 56m
Dec 31 2023	SEK 648k	SEK 504k	-SEK 56m

보상 대 시장: Pia 의 총 보상 ($USD 62.09K ) Swedish 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 257.75K ).

보상과 수익: Pia 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.

CEO

Pia Renaudin (57 yo)

less than a year

테뉴어

SEK 648,000

보상

Ms. Pia Renaudin serves as Chief Executive Officer at SciBase Holding AB (publ) since October 01, 2023 SciBaseHe served as Chief Executive Officer at Senzime AB (publ) since February 08, 2019 until May 03,...

리더십 팀

이름	위치	테뉴어	보상	소유권
Pia Renaudin	Chief Executive Officer	less than a year	SEK 648.00k	데이터 없음
Stig Ollmar	Founder & Chief Scientific Officer	26.5yrs	데이터 없음	데이터 없음
Michael Colérus	Chief Financial Officer	10.5yrs	SEK 272.54k	데이터 없음
Per Svedenhag	Head of Business Development & Marketing	9.5yrs	SEK 1.43m	데이터 없음
Tobias Bergenblad	Global Sales Director	9.5yrs	데이터 없음	데이터 없음
Leda Beaty	Head of US Commercial Operations	less than a year	데이터 없음	데이터 없음

9.5yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 관리: SCIB 의 관리팀은 노련하고 경험 (평균 재직 기간 9.4 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Thomas Taapken	Independent Director	7.2yrs	SEK 150.00k	데이터 없음
Matt Leavitt	Independent Director	3.2yrs	SEK 150.00k	데이터 없음
Per Nordberg	Deputy Director	7.5yrs	데이터 없음	데이터 없음
Jesper Hoiland	Chairman of the Board	less than a year	데이터 없음	데이터 없음
Allan Halpern	Member of Scientific Advisory Board	9.3yrs	데이터 없음	데이터 없음
Scott Menzies	Member of Scientific Advisory Board	9.3yrs	데이터 없음	데이터 없음
Diana Ferro	Independent Director	7.2yrs	SEK 150.00k	데이터 없음
David Elder	Member of Scientific Advisory Board	9.3yrs	데이터 없음	데이터 없음
Josep Malvehy	Member of Scientific Advisory Board	9.3yrs	데이터 없음	데이터 없음
Holger Hänßle	Member of Scientific Advisory Board	9.3yrs	데이터 없음	데이터 없음
Robert Molander	Director	less than a year	데이터 없음	데이터 없음
Jvalini Dwarkasing	Independent Director	2.8yrs	SEK 150.00k	데이터 없음

7.3yrs

평균 재임 기간

61.5yo

평균 연령

경험이 풍부한 이사회: SCIB 의 이사회는 경험(평균 재직 기간 7.3 년)으로 간주됩니다.

SciBase Holding 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

SciBase Holding AB (publ) Appoints Leda Beaty as Head of US Commercial Operations

SciBase Holding AB (publ), Annual General Meeting, May 17, 2024

SciBase Holding AB (publ) Appoints Nomination Committee

Chairman & Interim CEO recently bought kr534k worth of stock

Scibase Appoints Pia Renaudin as Chief Executive Officer

SciBase Holding AB (publ) Announces Executive Changes

Recent updates

SciBase Holding AB (publ) Appoints Leda Beaty as Head of US Commercial Operations

Consensus EPS estimates upgraded to kr0.22 loss, revenue downgraded

New minor risk - Profitability

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Forecast to breakeven in 2026

New major risk - Shareholder dilution

Scibase Announces the Launch of Ebarrier Score, the First Ai-Driven Skin Barrier Assessment Tool for Research and Cosmetic Testing

New minor risk - Shareholder dilution

Price target decreased by 13% to kr1.68

SciBase Holding AB (publ) has completed a Composite Units Offering.

Consensus EPS estimates upgraded to kr0.27 loss

Consensus revenue estimates fall by 11%

New major risk - Financial position

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 39% to kr4.30

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

SciBase Holding AB (publ) to Report Fiscal Year 2023 Results on Feb 21, 2024

SciBase Holding AB (publ) to Report Q1, 2024 Results on May 09, 2024

SciBase Holding AB (publ), Annual General Meeting, May 17, 2024

SciBase Holding AB (publ) Appoints Nomination Committee

New major risk - Market cap size

SciBase Holding AB Announces the Publication of A Collaborative Scientific Project with the Swiss Institute of Allergy and Asthma Research in Davos, Switzerland

Chairman & Interim CEO recently bought kr534k worth of stock

Scibase Appoints Pia Renaudin as Chief Executive Officer

Consensus EPS estimates fall by 33%

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

SciBase Holding AB (publ) Announces Executive Changes

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates upgraded to kr0.30 loss, revenue downgraded

Full year 2022 earnings: EPS misses analyst expectations

SciBase Holding AB (publ) to Report Nine Months, 2023 Results on Nov 10, 2023

Price target decreased to kr11.00

SciBase Holding AB (publ) to Report Fiscal Year 2022 Results on Feb 23, 2023

SciBase Holding AB (publ) Announces New Study Shows Nevisense Significantly Improves US Clinician's Decision-Making Beyond Dermoscopy

SciBase Holding AB (publ), Annual General Meeting, May 18, 2023

Is SciBase Holding (STO:SCIB) In A Good Position To Deliver On Growth Plans?

SciBase Holding AB Announces Nevisense Detects Skin Barrier Damage in Mice Caused by Household Detergents

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

SciBase Holding AB (publ) to Report Q3, 2022 Results on Nov 10, 2022

SciBase Holding AB (publ) Announces US Study Shows That EIS and Nevisense Significantly Improves Clinicians' Diagnostic Accuracy

Will SciBase Holding (STO:SCIB) Spend Its Cash Wisely?

SciBase Holding AB (publ) Study Shows Clinical Benefit of Nevisense

Full year 2021 earnings released: kr0.67 loss per share (vs kr1.12 loss in FY 2020)

CEO & President recently bought kr76k worth of stock

Independent Chairman recently bought kr504k worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Chief Financial Officer recently bought kr111k worth of stock

Third quarter 2021 earnings released: kr0.13 loss per share (vs kr0.20 loss in 3Q 2020)

We're Hopeful That SciBase Holding (STO:SCIB) Will Use Its Cash Wisely

Second quarter 2021 earnings released: kr0.19 loss per share (vs kr0.38 loss in 2Q 2020)

SciBase Holding AB (publ) announced that it has received SEK 71.214109 million in funding from Van Herk Investments B.V., Ostvast Capital Management Limited, and other investors

First quarter 2021 earnings released: kr0.15 loss per share (vs kr0.54 loss in 1Q 2020)

Scibase Receives Important European MDR Certification

SciBase Holding AB (publ) Submits First Reimbursement Application to CMS in Florida

Is SciBase Holding (STO:SCIB) In A Good Position To Deliver On Growth Plans?

David Melin Resigns as Head of Product Development of SciBase AB

Full year 2020 earnings released: kr1.12 loss per share (vs kr2.38 loss in FY 2019)

Revenue beats expectations

SciBase Holding AB (publ) to Report Q3, 2021 Results on Nov 11, 2021

Calculating The Intrinsic Value Of SciBase Holding AB (publ) (STO:SCIB)

SciBase Holding AB (publ) Announces New Study Published Validating Further Nevisense Indication, Non-Melanoma Skin Cancer

New 90-day high: kr4.85

Third quarter 2020 earnings released: kr0.20 loss per share

SciBase Holding AB (publ) to Report Fiscal Year 2020 Results on Feb 19, 2021

Scibase Holding AB (Publ) Announces Positive Step for US Reimbursement of Nevisense

SciBase Holding Releases Next Generation Platform, Nevisense Go

New 90-day high - kr4.14

Earnings released

CEO 보상 분석